Planning

Market Engagement Event for the provision of Isolators

  • Northumbria Healthcare Facilities Management Limited

F01: Prior information notice (prior information only)

Notice identifier: 2023/S 000-013426

Procurement identifier (OCID): ocds-h6vhtk-03c7e4

Published 11 May 2023, 11:20am



Section one: Contracting authority

one.1) Name and addresses

Northumbria Healthcare Facilities Management Limited

Units 7&8 Silver Fox Way, Cobalt Business Park

Tyne and Wear

NE27 0QJ

Contact

Mr Kevin Marshall

Email

kevin.marshall@nhct.nhs.uk

Telephone

+44 7979850934

Country

United Kingdom

Region code

UKC - North East (England)

Internet address(es)

Main address

https://nhfm.co.uk/

Buyer's address

https://nhfm.co.uk/

one.3) Communication

Additional information can be obtained from the above-mentioned address

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Market Engagement Event for the provision of Isolators

Reference number

DN669701

two.1.2) Main CPV code

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

two.1.3) Type of contract

Supplies

two.1.4) Short description

It is intended to host a Market Engagement Event for providers of VHP Isolator Technologies on the 25th May 2023 to be held on site at:

North East and North Cumbria Manufacturing Facility, Northumbria Healthcare NHS manufacturing and innovation hub, Seaton Delaval, Northumberland.

Companies interested in attending the event must contact Kevin Marshall e-mail kevin.marshall@northumbria-healthcare.nhs.uk to obtain an information pack.

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKC - North East (England)

two.2.4) Description of the procurement

NENC Provider Collaborative are looking to assess the feasibility of establishing an MHRA Specials licenced manufacturing facility capable of meeting Good Manufacturing Practice (GMP), quality and operational requirements to produce sterile medicines via aseptic manufacture.

The proposed output of this facility will be:

• 950,000 Ready to Administer (RtA) products

• 70,000 Systemic anti-cancer therapies and Monoclonal antibodies

• 70,000 Parenteral Nutrition products.

• 400,000 - 600,000 over labelled products.

In order to do this, we would like to understand the manufacturing equipment ( VHP Isolator Technologies ) available to produce the sterile medicines listed and how these will impact on the cleanroom design requirements.

It is intended to host a Market Engagement Event for providers of VHP Isolator Technologies on the 25th May 2023 to be held on site at:

North East and North Cumbria Manufacturing Facility, Northumbria Healthcare NHS manufacturing and innovation hub, Seaton Delaval, Northumberland.

Companies interested in attending the event must contact Kevin Marshall e-mail kevin.marshall@northumbria-healthcare.nhs.uk to obtain an information pack.

two.3) Estimated date of publication of contract notice

19 June 2023


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes